Journal article
PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model
- Abstract:
- Current therapies for Alzheimer’s disease (AD) are symptomatic and do not target the underlying Aβ pathology and other important hallmarks including neuronal loss. PPARγ-coactivator-1α (PGC-1α) is a cofactor for transcription factors including the peroxisome proliferator-activated receptor-γ (PPARγ), and it is involved in the regulation of metabolic genes, oxidative phosphorylation, and mitochondrial biogenesis. We previously reported that PGC-1α also regulates the transcription of β-APP cleaving enzyme (BACE1), the main enzyme involved in Aβ generation, and its expression is decreased in AD patients. We aimed to explore the potential therapeutic effect of PGC-1α by generating a lentiviral vector to express human PGC-1α and target it by stereotaxic delivery to hippocampus and cortex of APP23 transgenic mice at the preclinical stage of the disease. Four months after injection, APP23 mice treated with hPGC-1α showed improved spatial and recognition memory concomitant with a significant reduction in Aβ deposition, associated with a decrease in BACE1 expression. hPGC-1α overexpression attenuated the levels of proinflammatory cytokines and microglial activation. This effect was accompanied by a marked preservation of pyramidal neurons in the CA3 area and increased expression of neurotrophic factors. The neuroprotective effects were secondary to a reduction in Aβ pathology and neuroinflammation, because wild-type mice receiving the same treatment were unaffected. These results suggest that the selective induction of PGC-1α gene in specific areas of the brain is effective in targeting AD-related neurodegeneration and holds potential as therapeutic intervention for this disease.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 3.0MB, Terms of use)
-
- Publisher copy:
- 10.1073/pnas.1606171113
Authors
+ Alzheimer's Research UK
More from this funder
- Funding agency for:
- Sastre, M
- Grant:
- ARUK-ESG-2013-8
- Publisher:
- National Academy of Sciences
- Journal:
- Proceedings of the National Academy of Sciences More from this journal
- Volume:
- 113
- Issue:
- 43
- Pages:
- 12292-12297
- Publication date:
- 2016-10-10
- Acceptance date:
- 2016-09-02
- DOI:
- EISSN:
-
1091-6490
- Keywords:
- Pubs id:
-
pubs:655391
- UUID:
-
uuid:649750b7-3235-4e8b-a0b6-54fad33a6916
- Local pid:
-
pubs:655391
- Source identifiers:
-
655391
- Deposit date:
-
2016-10-27
Terms of use
- Copyright holder:
- © Proceedings of the National Academy of Sciences
- Copyright date:
- 2016
- Notes:
- © Proceedings of the National Academy of Sciences. This is an Open Access article. The final version is available online from National Academy of Sciences at: 10.1073/pnas.1606171113
If you are the owner of this record, you can report an update to it here: Report update to this record